Originally Posted by
Maxtrade
What qualifies as justified or not. They say it's 'unjustified' because they have recently advised fund managers to pump money in at last Cap Raise. They have to say that otherwise they look like they messed up.
There is still a lot of 'hope' built in to current SP at these levels, unknown when 'might' become profitable. Hope for US adoption. Many investors won't see it as a positive investment until they can see some lab test throughput, increases in customer base, medical adoption, growth in revenue, and see profitability at the end of the tunnel. At this stage their is still lot of speculation built into the current SP. The Update was as expected, sugar coating but nothing positively substantial to show any real forward momentum in sales/ adoption. If SP doesn't crest and stabilise above $1.0 on this minor recent rally, then we might see a dip back off SP 1.0 back down to 0.8 range again.
Unfortunately the numbers in May are not likely to look positive. This may be the time the SP takes a dip down off current levels and tests 0.80 again. Until then might see hopefuls hold SP above 0.90. Sad to see what's happening to hopeful holders in AIR this morning. That's what false hope can do, need to trust in the figures and real data when investing (rather than speculating). PEB currently needs some real traction to push it back up into an uptrend over $1. Otherwise inevitable 0.80 will be retested.